InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,618.26
(
0.00%
)
US TECH 100
19,264.80
(
2.16%
)
Dow Jones
41,503.10
(
0.00%
)
Brent Oil
73.96
(
2.18%
)
Bitcoin
63,062.42
(
2.25%
)
Post# of 964
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

midastouch017

Send PM Follow Ignore
Followers 144
Posts 27707
Boards Moderated 3
Alias Born 02/07/2004

midastouch017

Re: None

Thursday, 02/10/2022 5:39:10 AM

Thursday, February 10, 2022 5:39:10 AM

Post# of 964
Gamida Cell surges 22% following rolling BLA submission for omidubicel

Feb. 09, 2022 3:05 PM ETGamida Cell Ltd. (GMDA)

By: Jonathan Block, SA News Editor

Shares of Gamida Cell (GMDA +22.3%) have surged higher after the company today said it started a rolling submission of a Biologics License Application ("BLA") for omidubicel, a treatment for patients with blood cancers in need of stem cell transplant.

The company is aiming to complete the submission by Q2.

Although he rates Gamida Cell as a hold, Seeking Alpha contributor Bret Jensen says the company has a favorable risk/reward profile.


Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up